Q1 2020 13F Holders as of 3/31/2020
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
127M
-
Number of holders
-
48
-
Total 13F shares, excl. options
-
3.84M
-
Shares change
-
-216K
-
Total reported value, excl. options
-
$12.4M
-
Value change
-
-$1.23M
-
Number of buys
-
24
-
Number of sells
-
-18
-
Price
-
$3.23
Significant Holders of Organogenesis Holdings Inc. - Common Stock, $0.01 par value (ORGO) as of Q1 2020
55 filings reported holding ORGO - Organogenesis Holdings Inc. - Common Stock, $0.01 par value as of Q1 2020.
Organogenesis Holdings Inc. - Common Stock, $0.01 par value (ORGO) has 48 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.84M shares
of 127M outstanding shares and own 3.03% of the company stock.
Largest 10 shareholders include Prosight Management, LP (672K shares), BlackRock Inc. (651K shares), GRANAHAN INVESTMENT MANAGEMENT INC/MA (286K shares), VANGUARD GROUP INC (262K shares), GEODE CAPITAL MANAGEMENT, LLC (242K shares), NORTHERN TRUST CORP (206K shares), HUSSMAN STRATEGIC ADVISORS, INC. (200K shares), STATE STREET CORP (172K shares), BANK OF MONTREAL /CAN/ (124K shares), and CHARLES SCHWAB INVESTMENT MANAGEMENT INC (123K shares).
This table shows the top 48 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.